drug protocol number

NRG-HN002

drug sponsor

NRG Oncology King Faisal Specialist Hospital & Research Center

drug study

CISPLATIN (CISPLATYL )

drug trial site

KFSH & RC-R

drug status

Ongoing

drug phase